CD24 Expression May Play a Role as a Predictive Indicator and a Modulator of Cisplatin Treatment Response in Head and Neck Squamous Cellular Carcinoma

CD24: A Novel Cancer Biomarker in Laryngeal Squamous Cell Carcinoma

(2012) Yong Shi et al.   ORL-Journal for Oto-Rhino-Laryngology Head and Neck Surgery

CD24+ Liver Tumor-Initiating Cells Drive Self-Renewal and Tumor Initiation through STAT3-Mediated NANOG Regulation

(2011) Terence Kin Wah Lee et al.   Cell Stem Cell

Management of Recurrent Head and Neck Cancer

(2011) Bruce E. Brockstein   DRUGS

Isolation and characterization of tumorigenic extrahepatic cholangiocarcinoma cells with stem cell-like properties

(2010) Min Wang et al.   INTERNATIONAL JOURNAL OF CANCER

CD24, a Novel Cancer Biomarker, Predicting Disease-Free Survival of Non-small Cell Lung Carcinomas: A Retrospective Study of Prognostic Factor Analysis from the Viewpoint of Forthcoming (Seventh) New TNM Classification

(2010) Hyun Ju Lee et al.   Journal of Thoracic Oncology

CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells

(2010) M-Q Gao et al.   ONCOGENE

Cancer stem cells from colorectal cancer-derived cell lines

(2010) Trevor M. Yeung et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment

(2009) G. Bertolini et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

CD44+CD24− prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis

(2008) E M Hurt et al.   BRITISH JOURNAL OF CANCER

Head and neck cancer

(2008) Athanassios Argiris et al.   LANCET

CD44s and CD44v6 Expression in Head and Neck Epithelia

(2008) Brigitte Mack et al.   PLoS One